Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003138359 | SCV003818950 | uncertain significance | Combined oxidative phosphorylation defect type 21 | 2020-04-23 | criteria provided, single submitter | clinical testing | |
Houlden Lab, |
RCV003138359 | SCV003035510 | likely pathogenic | Combined oxidative phosphorylation defect type 21 | no assertion criteria provided | research |